Yin Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yin Wu has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Yuxin Li
National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun 130024, China
8 shared publications - Yongli Bao
National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun, China
7 shared publications - Chunlei Yu
National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun 130024, China
4 shared publications - Lihua Zheng
National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun 130024, China
4 shared publications - Ying Sun
National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun 130117, China
4 shared publications - Zhenbo Song
National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun, 130117, China
4 shared publications
Latest Publications
- 1 February 2021
- Published by American Scientific Publishers in Journal of Biobased Materials and Bioenergy
- Vol. 15 (1) , 42-49
Establishment of Raman Fingerprints and Localization of Main Components of Radix Angelicae sinensis from Different Origins
In this paper, confocal micro-Raman spectrum (CMR) was used to investigate the distribution of main components (ferulic acid and nicotinic acid) in Radix Angelicae sinensis (RAS). The ferulic acid and nicotinic acid were scanned to obtain their Raman spectra of single component; the RAS from different origins were scanned to obtain the Raman spectrum of RAS, and the Raman spectrum was compared with single component. The Raman spectrum of a single component was introduced into the map review to localize ferulic acid and nicotinic acid in RAS. In the results, the RAS from different origins showed strong similarity, with obvious characteristic peaks at 120 cm(-1), 140 cm(-1), 210 cm(-1), 480 cm(-1) and 1050 cm(-1). The characteristic peaks of ferulic acid are mainly concentrated in the spectrum range of 100-1100 cm(-1), with obvious characteristic peaks around 160 cm(-1), 50 cm(-1) and 1800 cm(-1); while the peaks of nicotinic acid mainly concentrated in the spectrum range of 100-1100 cm(-1), with obvious characteristic peaks around 120 cm(-1), 140 cm(-1), 810 cm(-1) and 1050 cm(-1). The red and the green color represent the locations of ferulic acid and nicotinic acid, respectively. In conclusion, CMR can be used to establish the Raman fingerprint library of RAS for a quick and accurate identify, and locate the known active components.
- 1 February 2021
- Published by American Scientific Publishers in Journal of Biobased Materials and Bioenergy
- Vol. 15 (1) , 42-49
Establishment of Raman Fingerprints and Localization of Main Components of Radix Angelicae sinensis from Different Origins
In this paper, confocal micro-Raman spectrum (CMR) was used to investigate the distribution of main components (ferulic acid and nicotinic acid) in Radix Angelicae sinensis (RAS). The ferulic acid and nicotinic acid were scanned to obtain their Raman spectra of single component; the RAS from different origins were scanned to obtain the Raman spectrum of RAS, and the Raman spectrum was compared with single component. The Raman spectrum of a single component was introduced into the map review to localize ferulic acid and nicotinic acid in RAS. In the results, the RAS from different origins showed strong similarity, with obvious characteristic peaks at 120 cm(-1), 140 cm(-1), 210 cm(-1), 480 cm(-1) and 1050 cm(-1). The characteristic peaks of ferulic acid are mainly concentrated in the spectrum range of 100-1100 cm(-1), with obvious characteristic peaks around 160 cm(-1), 50 cm(-1) and 1800 cm(-1); while the peaks of nicotinic acid mainly concentrated in the spectrum range of 100-1100 cm(-1), with obvious characteristic peaks around 120 cm(-1), 140 cm(-1), 810 cm(-1) and 1050 cm(-1). The red and the green color represent the locations of ferulic acid and nicotinic acid, respectively. In conclusion, CMR can be used to establish the Raman fingerprint library of RAS for a quick and accurate identify, and locate the known active components.
- 1 November 2020
- Published by Elsevier in Brain Research Bulletin
- Vol. 164, 361-371
Fas and GIT1 signalling in the prefrontal cortex mediate behavioural sensitization to methamphetamine in mice
- 1 November 2020
- Published by Elsevier in Brain Research Bulletin
- Vol. 164, 361-371
Fas and GIT1 signalling in the prefrontal cortex mediate behavioural sensitization to methamphetamine in mice
- Open Access
Inhibition of TGF-β Signaling in Gliomas by the Flavonoid Diosmetin Isolated from Dracocephalum peregrinum L.
Background: Dracocephalum peregrinum L., a traditional Kazakh medicine, has good expectorant, anti-cough, and to some degree, anti-asthmatic effects. Diosmetin (3′,5,7-trihydroxy-4′-methoxyflavone), a natural flavonoid found in traditional Chinese herbs, is the main flavonoid in D. peregrinum L. and has been used in various medicinal products because of its anticancer, antimicrobial, antioxidant, estrogenic, and anti-inflammatory effects. The present study aimed to investigate the effects of diosmetin on the proliferation, invasion, and migration of glioma cells, as well as the possible underlying mechanisms. Methods: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), scratch wound, and Transwell assays were used to demonstrate the effects of diosmetin in glioma. Protein levels of Bcl-2, Bax, cleaved caspase-3, transforming growth factor-β (TGF-β), E-cadherin, and phosphorylated and unphosphorylated smad2 and smad3 were determined by Western blots. U251 glioma cell development and progression were measured in vivo in a mouse model. Results: Diosmetin inhibited U251 cell proliferation, migration, and invasion in vitro, the TGF-β signaling pathway, and Bcl-2 expression. In contrast, there was a significant increase in E-cadherin, Bax, and cleaved caspase-3 expression. Furthermore, it effectively reduced the tumorigenicity of glioma cells and promoted apoptosis in vivo. Conclusion: The results of this study suggest that diosmetin suppresses the growth of glioma cells in vitro and in vivo, possibly by activating E-cadherin expression and inhibiting the TGF-β signaling pathway.
Open AccessInhibition of TGF-β Signaling in Gliomas by the Flavonoid Diosmetin Isolated from Dracocephalum peregrinum L.
Background: Dracocephalum peregrinum L., a traditional Kazakh medicine, has good expectorant, anti-cough, and to some degree, anti-asthmatic effects. Diosmetin (3′,5,7-trihydroxy-4′-methoxyflavone), a natural flavonoid found in traditional Chinese herbs, is the main flavonoid in D. peregrinum L. and has been used in various medicinal products because of its anticancer, antimicrobial, antioxidant, estrogenic, and anti-inflammatory effects. The present study aimed to investigate the effects of diosmetin on the proliferation, invasion, and migration of glioma cells, as well as the possible underlying mechanisms. Methods: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), scratch wound, and Transwell assays were used to demonstrate the effects of diosmetin in glioma. Protein levels of Bcl-2, Bax, cleaved caspase-3, transforming growth factor-β (TGF-β), E-cadherin, and phosphorylated and unphosphorylated smad2 and smad3 were determined by Western blots. U251 glioma cell development and progression were measured in vivo in a mouse model. Results: Diosmetin inhibited U251 cell proliferation, migration, and invasion in vitro, the TGF-β signaling pathway, and Bcl-2 expression. In contrast, there was a significant increase in E-cadherin, Bax, and cleaved caspase-3 expression. Furthermore, it effectively reduced the tumorigenicity of glioma cells and promoted apoptosis in vivo. Conclusion: The results of this study suggest that diosmetin suppresses the growth of glioma cells in vitro and in vivo, possibly by activating E-cadherin expression and inhibiting the TGF-β signaling pathway.
- Open Access
- 13 September 2017
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 8, 1738
Anti-biofilm Activities from Bergenia crassifolia Leaves against Streptococcus mutans
Streptococcus mutans has been reported as a primary cariogenic pathogen associated with dental caries. The bacteria can produce glucosyltransferases (Gtfs) to synthesize extracellular polysaccharides (EPSs) that are known as virulence factors for adherence and formation of biofilms. Therefore, an ideal inhibitor for dental caries is one that can inhibit planktonic bacteria growth and prevent biofilm formation. Bergenia crassifolia (L.), widely used as a folk medicine and tea beverage, has been reported to have a variety of bioactivities. The present study aimed to explore the effect of B. crassifolia (L.) leaf extracts on the biofilm of Streptococcus mutans. The B. crassifolia (L.) leaf extracts showed inhibitory effects by decreasing viability of bacteria within the biofilm, as evidenced by the XTT assay, live/dead staining assay and LDH activity assay, and could decrease the adherence property of S. mutans through inhibiting Gtfs to synthesize EPSs. In addition, the reduced quantity of EPSs and the inhibition of Gtfs were positively correlated with concentrations of test samples. Finally, the MTT assay showed that the extracts had no cytotoxicity against normal oral cells. In conclusion, the extracts and sub-extracts of B. crassifolia leaves were found to be antimicrobial and could reduce EPS synthesis by inhibiting activities of Gtfs to prevent bacterial adhesion and biofilm formation. Therefore, B. crassifolia leaves have potential to be developed as a drug to prevent and cure dental caries.
- 13 September 2017
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 8, 1738
Open AccessAnti-biofilm Activities from Bergenia crassifolia Leaves against Streptococcus mutans
Streptococcus mutans has been reported as a primary cariogenic pathogen associated with dental caries. The bacteria can produce glucosyltransferases (Gtfs) to synthesize extracellular polysaccharides (EPSs) that are known as virulence factors for adherence and formation of biofilms. Therefore, an ideal inhibitor for dental caries is one that can inhibit planktonic bacteria growth and prevent biofilm formation. Bergenia crassifolia (L.), widely used as a folk medicine and tea beverage, has been reported to have a variety of bioactivities. The present study aimed to explore the effect of B. crassifolia (L.) leaf extracts on the biofilm of Streptococcus mutans. The B. crassifolia (L.) leaf extracts showed inhibitory effects by decreasing viability of bacteria within the biofilm, as evidenced by the XTT assay, live/dead staining assay and LDH activity assay, and could decrease the adherence property of S. mutans through inhibiting Gtfs to synthesize EPSs. In addition, the reduced quantity of EPSs and the inhibition of Gtfs were positively correlated with concentrations of test samples. Finally, the MTT assay showed that the extracts had no cytotoxicity against normal oral cells. In conclusion, the extracts and sub-extracts of B. crassifolia leaves were found to be antimicrobial and could reduce EPS synthesis by inhibiting activities of Gtfs to prevent bacterial adhesion and biofilm formation. Therefore, B. crassifolia leaves have potential to be developed as a drug to prevent and cure dental caries.
- Open Access
- 10 April 2017
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (4) , 794
Ginkgolide A Ameliorates LPS-Induced Inflammatory Responses In Vitro and In Vivo
Ginkgolide A (GA) is a natural compound isolated from Ginkgo biloba and has been used to treat cardiovascular diseases and diabetic vascular complications. However, only a few studies have been conducted on the anti-inflammatory effects of GA. In particular, no related reports have been published in a common inflammation model of lipopolysaccharide (LPS)-stimulated macrophages, and the anti-inflammatory mechanisms of GA have not been fully elucidated. In the present study, we extensively investigated the anti-inflammatory potential of GA in vitro and in vivo. We showed that GA could suppress the expression of pro-inflammatory mediators (cyclooxygenase-2 (COX-2) and nitric oxide (NO) and pro-inflammatory cytokines (tumor necrosis factor (TNF)-α, interleukin (IL)-6 and IL-1β) in LPS-treated mouse peritoneal macrophages, mouse macrophage RAW264.7 cells, and differentiated human monocytes (dTHP-1) in vitro. These effects were partially carried out via downregulating Nuclear factor kappa-B (NF-κB), Mitogen-activated protein kinases (MAPKs) (p38 mitogen-activated protein kinase and extracellular signal-regulated kinase (ERK), but not c-Jun N-terminal kinase (JNK), and activating the AMP-activated protein kinase (AMPK) signaling pathway also seems to be important. Consistently, GA was also shown to inhibit the LPS-stimulated release of TNF-α and IL-6 in mice. Taken together, these findings suggest that GA can serve as an effective inflammatory inhibitor in vitro and in vivo.
- 10 April 2017
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (4) , 794
Open AccessGinkgolide A Ameliorates LPS-Induced Inflammatory Responses In Vitro and In Vivo
Ginkgolide A (GA) is a natural compound isolated from Ginkgo biloba and has been used to treat cardiovascular diseases and diabetic vascular complications. However, only a few studies have been conducted on the anti-inflammatory effects of GA. In particular, no related reports have been published in a common inflammation model of lipopolysaccharide (LPS)-stimulated macrophages, and the anti-inflammatory mechanisms of GA have not been fully elucidated. In the present study, we extensively investigated the anti-inflammatory potential of GA in vitro and in vivo. We showed that GA could suppress the expression of pro-inflammatory mediators (cyclooxygenase-2 (COX-2) and nitric oxide (NO) and pro-inflammatory cytokines (tumor necrosis factor (TNF)-α, interleukin (IL)-6 and IL-1β) in LPS-treated mouse peritoneal macrophages, mouse macrophage RAW264.7 cells, and differentiated human monocytes (dTHP-1) in vitro. These effects were partially carried out via downregulating Nuclear factor kappa-B (NF-κB), Mitogen-activated protein kinases (MAPKs) (p38 mitogen-activated protein kinase and extracellular signal-regulated kinase (ERK), but not c-Jun N-terminal kinase (JNK), and activating the AMP-activated protein kinase (AMPK) signaling pathway also seems to be important. Consistently, GA was also shown to inhibit the LPS-stimulated release of TNF-α and IL-6 in mice. Taken together, these findings suggest that GA can serve as an effective inflammatory inhibitor in vitro and in vivo.
- 15 July 2014
- Published by Elsevier in Cellular Signalling
- Vol. 26 (10) , 2266-2275
The catalytic triad of testes-specific protease 50 (TSP50) is essential for its function in cell proliferation
- 15 July 2014
- Published by Elsevier in Cellular Signalling
- Vol. 26 (10) , 2266-2275
The catalytic triad of testes-specific protease 50 (TSP50) is essential for its function in cell proliferation
- 16 November 2013
- Published by Elsevier in Toxicology Letters
- Vol. 224 (3) , 349-355
Alantolactone induces cell apoptosis partially through down-regulation of testes-specific protease 50 expression
- 16 November 2013
- Published by Elsevier in Toxicology Letters
- Vol. 224 (3) , 349-355
Alantolactone induces cell apoptosis partially through down-regulation of testes-specific protease 50 expression
- 18 February 2013
- Published by Wiley in Helvetica Chimica Acta
- Vol. 96 (2) , 330-337
Four New Alkaloids from the Fermentation Broth of Armillaria mellea
- 18 February 2013
- Published by Wiley in Helvetica Chimica Acta
- Vol. 96 (2) , 330-337
Four New Alkaloids from the Fermentation Broth of Armillaria mellea
- Open Access
- 6 February 2013
- Published by Springer Nature in BMC Bioinformatics
- Vol. 14 (1) , 41
Elucidating the crosstalk mechanism between IFN-gamma and IL-6 via mathematical modelling
Background: Interferon-gamma (IFN-gamma) and interleukin-6 (IL-6) are multifunctional cytokines that regulate immune responses, cell proliferation, and tumour development and progression, which frequently have functionally opposing roles. The cellular responses to both cytokines are activated via the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway. During the past 10 years, the crosstalk mechanism between the IFN-gamma and IL-6 pathways has been studied widely and several biological hypotheses have been proposed, but the kinetics and detailed crosstalk mechanism remain unclear. Results: Using established mathematical models and new experimental observations of the crosstalk between the IFN-gamma and IL-6 pathways, we constructed a new crosstalk model that considers three possible crosstalk levels: (1) the competition between STAT1 and STAT3 for common receptor docking sites; (2) the mutual negative regulation between SOCS1 and SOCS3; and (3) the negative regulatory effects of the formation of STAT1/3 heterodimers. A number of simulations were tested to explore the consequences of cross-regulation between the two pathways. The simulation results agreed well with the experimental data, thereby demonstrating the effectiveness and correctness of the model. Conclusion: In this study, we developed a crosstalk model of the IFN-gamma and IL-6 pathways to theoretically investigate their cross-regulation mechanism. The simulation experiments showed the importance of the three crosstalk levels between the two pathways. In particular, the unbalanced competition between STAT1 and STAT3 for IFNR and gp130 led to preferential activation of IFN-gamma and IL-6, while at the same time the formation of STAT1/3 heterodimers enhanced preferential signal transduction by sequestering a fraction of the activated STATs. The model provided a good explanation of the experimental observations and provided insights that may inform further research to facilitate a better understanding of the cross-regulation mechanism between the two pathways.
- 6 February 2013
- Published by Springer Nature in BMC Bioinformatics
- Vol. 14 (1) , 41
Open AccessElucidating the crosstalk mechanism between IFN-gamma and IL-6 via mathematical modelling
Background: Interferon-gamma (IFN-gamma) and interleukin-6 (IL-6) are multifunctional cytokines that regulate immune responses, cell proliferation, and tumour development and progression, which frequently have functionally opposing roles. The cellular responses to both cytokines are activated via the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway. During the past 10 years, the crosstalk mechanism between the IFN-gamma and IL-6 pathways has been studied widely and several biological hypotheses have been proposed, but the kinetics and detailed crosstalk mechanism remain unclear. Results: Using established mathematical models and new experimental observations of the crosstalk between the IFN-gamma and IL-6 pathways, we constructed a new crosstalk model that considers three possible crosstalk levels: (1) the competition between STAT1 and STAT3 for common receptor docking sites; (2) the mutual negative regulation between SOCS1 and SOCS3; and (3) the negative regulatory effects of the formation of STAT1/3 heterodimers. A number of simulations were tested to explore the consequences of cross-regulation between the two pathways. The simulation results agreed well with the experimental data, thereby demonstrating the effectiveness and correctness of the model. Conclusion: In this study, we developed a crosstalk model of the IFN-gamma and IL-6 pathways to theoretically investigate their cross-regulation mechanism. The simulation experiments showed the importance of the three crosstalk levels between the two pathways. In particular, the unbalanced competition between STAT1 and STAT3 for IFNR and gp130 led to preferential activation of IFN-gamma and IL-6, while at the same time the formation of STAT1/3 heterodimers enhanced preferential signal transduction by sequestering a fraction of the activated STATs. The model provided a good explanation of the experimental observations and provided insights that may inform further research to facilitate a better understanding of the cross-regulation mechanism between the two pathways.
- 17 January 2013
- Published by Taylor & Francis in Journal of Asian Natural Products Research
- Vol. 15 (2) , 203-208
A new compound from liquid fermentation broth ofArmillaria melleaand the determination of its absolute configuration
A new 2,5-diketopiperazine, (R)-2-(2-(furan-2-yl)-oxoethyl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione, and seven known compounds were isolated from the ethyl acetate extract of liquid fermentation broth of Armillaria mellea. The structures of the isolated compounds were established from NMR and HR-MS data. The absolute configuration of the new compound was established by comparing the experimental electronic circular dichroism (ECD) spectrum with the calculated ECD data.
- 17 January 2013
- Published by Taylor & Francis in Journal of Asian Natural Products Research
- Vol. 15 (2) , 203-208
A new compound from liquid fermentation broth ofArmillaria melleaand the determination of its absolute configuration
A new 2,5-diketopiperazine, (R)-2-(2-(furan-2-yl)-oxoethyl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione, and seven known compounds were isolated from the ethyl acetate extract of liquid fermentation broth of Armillaria mellea. The structures of the isolated compounds were established from NMR and HR-MS data. The absolute configuration of the new compound was established by comparing the experimental electronic circular dichroism (ECD) spectrum with the calculated ECD data.